JAZZ logo

Jazz Pharmaceuticals (JAZZ) Retained earnings

annual retained earnings:

$1.13B+$248.69M(+28.30%)
December 31, 2024

Summary

  • As of today (May 21, 2025), JAZZ annual retained earnings is $1.13 billion, with the most recent change of +$248.69 million (+28.30%) on December 31, 2024.
  • During the last 3 years, JAZZ annual retained earnings has risen by +$297.12 million (+35.79%).
  • JAZZ annual retained earnings is now -2.81% below its all-time high of $1.16 billion, reached on December 31, 2020.

Performance

JAZZ Retained earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherJAZZbalance sheet metrics

quarterly retained earnings:

$1.03B-$92.54M(-8.21%)
March 1, 2025

Summary

  • As of today (May 21, 2025), JAZZ quarterly retained earnings is $1.03 billion, with the most recent change of -$92.54 million (-8.21%) on March 1, 2025.
  • Over the past year, JAZZ quarterly retained earnings has increased by +$170.77 million (+19.76%).
  • JAZZ quarterly retained earnings is now -19.26% below its all-time high of $1.28 billion, reached on March 31, 2021.

Performance

JAZZ quarterly retained earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherJAZZbalance sheet metrics

Retained earnings Formula

Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid

JAZZ Retained earnings Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+28.3%+19.8%
3 y3 years+35.8%+7.9%
5 y5 years+5.6%+34.2%

JAZZ Retained earnings Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+53.7%-8.2%+41.1%
5 y5-year-2.8%+53.7%-19.3%+41.1%
alltimeall time-2.8%+322.1%-19.3%+301.4%

JAZZ Retained earnings History

DateAnnualQuarterly
Mar 2025
-
$1.03B(-8.2%)
Dec 2024
$1.13B(+28.3%)
$1.13B(+20.4%)
Sep 2024
-
$936.23M(+7.5%)
Jun 2024
-
$871.18M(+0.8%)
Mar 2024
-
$864.04M(-1.7%)
Dec 2023
$878.66M(+19.8%)
$878.66M(-0.6%)
Sep 2023
-
$884.30M(+8.9%)
Jun 2023
-
$811.85M(+1.1%)
Mar 2023
-
$803.01M(+9.5%)
Dec 2022
$733.59M(-11.6%)
$733.59M(-24.7%)
Sep 2022
-
$974.31M(-2.0%)
Jun 2022
-
$993.96M(+3.6%)
Mar 2022
-
$959.35M(+15.6%)
Dec 2021
$830.23M(-28.4%)
$830.23M(-4.1%)
Sep 2021
-
$865.58M(-5.8%)
Jun 2021
-
$918.41M(-28.3%)
Mar 2021
-
$1.28B(+10.5%)
Dec 2020
$1.16B(+8.6%)
$1.16B(+13.0%)
Sep 2020
-
$1.03B(+16.9%)
Jun 2020
-
$878.25M(+13.9%)
Mar 2020
-
$770.93M(-27.8%)
Dec 2019
$1.07B(+27.0%)
$1.07B(-3.3%)
Sep 2019
-
$1.10B(+8.1%)
Jun 2019
-
$1.02B(+24.6%)
Mar 2019
-
$819.85M(-2.5%)
Dec 2018
$841.05M(-8.4%)
$841.05M(-25.5%)
Sep 2018
-
$1.13B(+12.8%)
Jun 2018
-
$1.00B(+7.7%)
Mar 2018
-
$929.05M(+1.2%)
Dec 2017
$917.96M(+73.6%)
$917.96M(+26.1%)
Sep 2017
-
$728.12M(+5.5%)
Jun 2017
-
$690.16M(+14.7%)
Mar 2017
-
$601.52M(+13.7%)
Dec 2016
$528.91M(+74.7%)
$528.91M(+67.7%)
Sep 2016
-
$315.42M(-2.9%)
Jun 2016
-
$324.84M(+34.0%)
Mar 2016
-
$242.44M(-19.9%)
DateAnnualQuarterly
Dec 2015
$302.69M(+772.2%)
$302.69M(+16.3%)
Sep 2015
-
$260.18M(+43.1%)
Jun 2015
-
$181.83M(+91.3%)
Mar 2015
-
$95.07M(+173.9%)
Dec 2014
$34.70M(+87.3%)
$34.70M(-200.1%)
Sep 2014
-
-$34.67M(-35.7%)
Jun 2014
-
-$53.95M(-27.2%)
Mar 2014
-
-$74.12M(-499.9%)
Dec 2013
$18.53M(-130.2%)
$18.53M(-793.0%)
Sep 2013
-
-$2.67M(-90.9%)
Jun 2013
-
-$29.26M(+63.8%)
Mar 2013
-
-$17.87M(-70.8%)
Dec 2012
-$61.30M(-82.5%)
-$61.30M(-76.6%)
Sep 2012
-
-$261.85M(-11.3%)
Jun 2012
-
-$295.06M(-8.4%)
Mar 2012
-
-$322.20M(-7.9%)
Dec 2011
-$349.88M(-26.3%)
-$349.88M(-9.7%)
Sep 2011
-
-$387.36M(-7.7%)
Jun 2011
-
-$419.84M(-7.3%)
Mar 2011
-
-$453.04M(-4.6%)
Dec 2010
-$474.87M(-6.5%)
-$474.87M(-7.4%)
Jun 2010
-
-$512.57M(+1.3%)
Mar 2010
-
-$506.18M(-0.3%)
Dec 2009
-$507.64M(+1.4%)
-$507.64M(-1.1%)
Sep 2009
-
-$513.30M(+0.3%)
Jun 2009
-
-$511.63M(-0.4%)
Mar 2009
-
-$513.80M(+2.6%)
Dec 2008
-$500.81M(+58.2%)
-$500.81M(+12.8%)
Sep 2008
-
-$443.87M(+6.9%)
Jun 2008
-
-$415.06M(+14.3%)
Mar 2008
-
-$363.18M(+14.8%)
Dec 2007
-$316.47M(+78.1%)
-$316.47M(+23.4%)
Sep 2007
-
-$256.45M(+8.2%)
Jun 2007
-
-$237.09M(+20.2%)
Mar 2007
-
-$197.23M(+11.0%)
Dec 2006
-$177.64M(+50.2%)
-$177.64M(+50.2%)
Dec 2005
-$118.25M
-$118.25M

FAQ

  • What is Jazz Pharmaceuticals annual retained earnings?
  • What is the all time high annual retained earnings for Jazz Pharmaceuticals?
  • What is Jazz Pharmaceuticals annual retained earnings year-on-year change?
  • What is Jazz Pharmaceuticals quarterly retained earnings?
  • What is the all time high quarterly retained earnings for Jazz Pharmaceuticals?
  • What is Jazz Pharmaceuticals quarterly retained earnings year-on-year change?

What is Jazz Pharmaceuticals annual retained earnings?

The current annual retained earnings of JAZZ is $1.13B

What is the all time high annual retained earnings for Jazz Pharmaceuticals?

Jazz Pharmaceuticals all-time high annual retained earnings is $1.16B

What is Jazz Pharmaceuticals annual retained earnings year-on-year change?

Over the past year, JAZZ annual retained earnings has changed by +$248.69M (+28.30%)

What is Jazz Pharmaceuticals quarterly retained earnings?

The current quarterly retained earnings of JAZZ is $1.03B

What is the all time high quarterly retained earnings for Jazz Pharmaceuticals?

Jazz Pharmaceuticals all-time high quarterly retained earnings is $1.28B

What is Jazz Pharmaceuticals quarterly retained earnings year-on-year change?

Over the past year, JAZZ quarterly retained earnings has changed by +$170.77M (+19.76%)
On this page